Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study.

In English

Författare

  • Elizabeth K Bancroft
  • Elizabeth C Page
  • Elena Castro
  • Hans Lilja
  • Andrew Vickers
  • Daniel Sjoberg
  • Melissa Assel
  • Christopher S Foster
  • Gillian Mitchell
  • Kate Drew
  • Lovise Mæhle
  • Karol Axcrona
  • D Gareth Evans
  • Barbara Bulman
  • Diana Eccles
  • Donna McBride
  • Christi van Asperen
  • Hans Vasen
  • Lambertus A Kiemeney
  • Janneke Ringelberg
  • Cezary Cybulski
  • Dominika Wokolorczyk
  • Christina Selkirk
  • Peter J Hulick
  • Anders Bojesen
  • Anne-Bine Skytte
  • Jimmy Lam
  • Louise Taylor
  • Rogier Oldenburg
  • Ruben Cremers
  • Gerald Verhaegh
  • Wendy A van Zelst-Stams
  • Jan C Oosterwijk
  • Ignacio Blanco
  • Monica Salinas
  • Jackie Cook
  • Derek J Rosario
  • Saundra Buys
  • Tom Conner
  • Margreet G Ausems
  • Kai-Ren Ong
  • Jonathan Hoffman
  • Susan Domchek
  • Jacquelyn Powers
  • Manuel R Teixeira
  • Sofia Maia
  • William D Foulkes
  • Nassim Taherian
  • Marielle Ruijs
  • Apollonia T Helderman-van den Enden
  • Louise Izatt
  • Rosemarie Davidson
  • Muriel A Adank
  • Lisa Walker
  • Rita Schmutzler
  • Kathy Tucker
  • Judy Kirk
  • Shirley Hodgson
  • Marion Harris
  • Fiona Douglas
  • Geoffrey J Lindeman
  • Janez Zgajnar
  • Marc Tischkowitz
  • Virginia E Clowes
  • Rachel Susman
  • Teresa Ramón Y Cajal
  • Nicholas Patcher
  • Neus Gadea
  • Allan Spigelman
  • Theo van Os
  • Annelie Liljegren
  • Lucy Side
  • Carole Brewer
  • Angela F Brady
  • Alan Donaldson
  • Vigdis Stefansdottir
  • Eitan Friedman
  • Rakefet Chen-Shtoyerman
  • David J Amor
  • Lucia Copakova
  • Julian Barwell
  • Veda N Giri
  • Vedang Murthy
  • Nicola Nicolai
  • Soo-Hwang Teo
  • Lynn Greenhalgh
  • Sara Strom
  • Alex Henderson
  • John McGrath
  • David Gallagher
  • Neil Aaronson
  • Audrey Ardern-Jones
  • Chris Bangma
  • David Dearnaley
  • Philandra Costello
  • Jorunn Eyfjord
  • Jeanette Rothwell
  • Alison Falconer
  • Henrik Gronberg
  • Freddie C Hamdy
  • Oskar Johannsson
  • Vincent Khoo
  • Zsofia Kote-Jarai
  • Jan Lubinski
  • Ulrika Axcrona
  • Jane Melia
  • Joanne McKinley
  • Anita V Mitra
  • Clare Moynihan
  • Gad Rennert
  • Mohnish Suri
  • Penny Wilson
  • Emma Killick
  • Sue Moss
  • Rosalind A Eeles
Visa allt

Summary, in English

Men with germline breast cancer 1, early onset (BRCA1) or breast cancer 2, early onset (BRCA2) gene mutations have a higher risk of developing prostate cancer (PCa) than noncarriers. IMPACT (Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in BRCA1/2 mutation carriers and controls) is an international consortium of 62 centres in 20 countries evaluating the use of targeted PCa screening in men with BRCA1/2 mutations.

Publiceringsår

2014-01-15

Språk

Engelska

Publikation/Tidskrift/Serie

European Urology

Dokumenttyp

Artikel i tidskrift

Förlag

Elsevier

Ämne

  • Urology and Nephrology

Status

Published

Forskningsgrupp

  • Clinical Chemistry, Malmö

ISBN/ISSN/Övrigt

  • ISSN: 1873-7560